Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.1K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.5K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Protein Networks02:26

Protein Networks

4.3K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.3K
Ligand Binding Sites02:40

Ligand Binding Sites

14.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.3K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.5K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated deep learning and multi-scale modeling for the discovery of pan-genotypic HCV NS5B polymerase inhibitors.

Molecular diversity·2026
Same author

Surface characteristics and initial supragingival biofilm formation on additively manufactured zirconia and resin: An in situ study.

Journal of dentistry·2026
Same author

SERINC3 promotes osteogenic differentiation of BMSCs via IL-32/AMPK-mediated autophagy and mitochondrial energy metabolism.

Stem cell research & therapy·2026
Same author

The influence of a type I antifreeze protein and its mutants on methane hydrate adsorption-inhibition: A molecular dynamics simulation study.

The Journal of chemical physics·2026
Same author

Effects of a Plant-Derived Protein Diet Supplemented With Multi-Strain Probiotics on Muscle Mass, Muscle Strength, and Gut Microbiota in Aged Rats.

Molecular nutrition & food research·2026
Same author

The effect of dental floss sequence on plaque removal efficacy and periodontal health: a randomized controlled trial.

BMC oral health·2026

Related Experiment Video

Updated: Nov 8, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.1K

KenDTI: An Ensemble Model for Predicting Drug-Target Interaction by Integrating Multi-Source Information.

Zhimiao Yu, Jiarui Lu, Yuan Jin

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |April 20, 2021
    PubMed
    Summary

    This study introduces KenDTI, an ensemble model for predicting drug-target interactions (DTIs). KenDTI integrates network and sequence data, outperforming existing methods and handling scarce information for drug discovery.

    More Related Videos

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
    08:49

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

    Published on: June 20, 2025

    710
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.4K

    Related Experiment Videos

    Last Updated: Nov 8, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.1K
    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
    08:49

    Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

    Published on: June 20, 2025

    710
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.4K

    Area of Science:

    • Computational Biology
    • Bioinformatics
    • Drug Discovery

    Background:

    • Drug-target interaction (DTI) identification is crucial for drug discovery but experimental validation is costly and inefficient.
    • Computational models are vital for predicting potential DTIs, with performance depending on feature extraction from drugs and proteins.

    Purpose of the Study:

    • To develop an advanced computational model for accurate DTI prediction by combining diverse data sources and methodologies.
    • To improve DTI prediction performance by leveraging both network-based and classification-based approaches.

    Main Methods:

    • Exploited biochemical drug characteristics using network integration.
    • Utilized molecular sequences via word embeddings for feature representation.
    • Developed an ensemble model, KenDTI, integrating network-based and classification-based methods.

    Main Results:

    • KenDTI demonstrated superior performance compared to state-of-the-art DTI predictors on large-scale datasets.
    • The model showed robustness against missing network data and limited prior knowledge.
    • Successfully predicted DTIs for drug candidates with scarce information.

    Conclusions:

    • Ensemble modeling integrating network and sequence data significantly enhances DTI prediction accuracy.
    • KenDTI offers a robust and versatile tool for drug discovery, particularly for compounds with limited data.
    • The developed approach advances computational drug discovery by improving the efficiency and reliability of identifying potential drug-target interactions.